Shexiang Baoxin Pill for Acute Myocardial Infarction: Clinical Evidence and Molecular Mechanism of Antioxidative Stress

Acute myocardial infarction (AMI) has been a preclinical and clinical concern due to high hospitalization rate and mortality. This study was aimed at evaluating the effectiveness and safety of Shexiang Baoxin Pill (SBP) for AMI and exploring the possible mechanism of oxidative stress. Six databases...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jianbo, Qin, Zongshi, He, Qingyong, Fong, Tung Leong, Lau, Ngai Chung, Cho, William C. S., Zhang, Hui, Meng, Peipei, Xing, Xiaoxiao, Li, Min, Zhang, Zhang-Jin, Chen, Haiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652282/
https://www.ncbi.nlm.nih.gov/pubmed/34900089
http://dx.doi.org/10.1155/2021/7644648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652282/
https://www.ncbi.nlm.nih.gov/pubmed/34900089
http://dx.doi.org/10.1155/2021/7644648

Ejemplares similares